0 Interference No. 104,522 Paper108 Nichols v. Tabakoff Page 62 V. the letter of March 17, 1997 (Ex 2006) This letter suggests that a "major squabble" (Ex 2006, p. 2, last 1) was developing between Tabakoff and Nichols. 111. Dr. Tabakoff wrote: I reiterate that the original idea to generate the dichlorodiphenylureidokynurenates belonged to me ... I do not argue the fact that you and Al Nichols, when asked, generated the synthetic scheme by which the kynurenate derivatives were synthesized .... [Ex 2006, p . 1, If you and Al wish to patent the chemical synthesis of the kynurenate derivatives, I certainly will not stand in your way... Given the information we have shared with you, it should be clear that not only the original idea, but its reduction to practice, has been pursued successfully in our laboratories. [Ex 2006, p. 1, 12.] Again, the letter of March 17, 1997 is not inconsistent with a good faith disagreement over joint inventorship of Tabakoffs claimed compounds or with Nichols inventorship of a possibly patentable method of synthesizing 4-urea kynurenates. vi. the letter of April 17, 1997 (Ex 2007) 112. Dr. Tabakoff refers to "the route of synthesis for the DCUKs [dichloro-diphenyl ureido-kynurenates] as developed by you [Dr. Yielding] and Al Nichols" (Ex 2007, p. 2, 11); a possible "'prior art' [issue] with regard to patents already filed by Merck" (Ld., p. 2, 12), and states: In terms of inventorship and other business-related issues, I would want the following: Given that the idea for the DCUKs originated with me, and given that I directed the work in our laboratories on establishing the biological activity of these compounds, I would like my name to appear first on a list of inventors. This would be followed by the names of A] Nichols, Lawrence Snell, and you and Paula Hoffman. That patent would be assigned to Lochocla Research Corporation. Lohocla would enter into a contractual agreement with Yielding and Daugherty ResearchPage: Previous 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 NextLast modified: November 3, 2007